Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

ABSTRAL

PALADIN LABS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ABSTRAL discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ABSTRAL 600MCG has been permanently discontinued (last updated July 26, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ABSTRAL not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist — only products with a different form or route found
StatusPermanently Discontinued
Same-ingredient products on file6 products · 0 same form & route
Affected strength600MCG
Report last updated2018-07-26
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

FENTANYL CITRATE INJECTION USP

SANDOZ CANADA INCORPORATED

50MCG · DIN 02240434

Different strengthDifferent dosage formDifferent routeNo current shortage

TEVA-FENTANYL

TEVA CANADA LIMITED

75MCG · DIN 02282976

Different strengthDifferent dosage formDifferent routeNo current shortage

SANDOZ FENTANYL PATCH

SANDOZ CANADA INCORPORATED

12MCG · DIN 02327112

Different strengthDifferent dosage formDifferent routeNo current shortage

FENTORA

PHOENIX LABS UNLIMITED COMPANY

400MCG · DIN 02408023

Different strengthDifferent dosage formDifferent routeNo current shortage

FENTANYL INJECTION BP

STERIMAX INC

1000MCG · DIN 02496178

Different strengthDifferent dosage formDifferent routeNo current shortage

FENTANYL CITRATE INJECTION, USP

FRESENIUS KABI CANADA LTD

50MCG · DIN 02501554

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02364212

Strength

600MCG

Dosage Form

TABLET

Route

SUBLINGUAL

Active Ingredient

FENTANYL

See all FENTANYL products →

Shortage History